These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30803040)

  • 21. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
    Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
    Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression.
    Baak JP; Van Diermen B; Steinbakk A; Janssen E; Skaland I; Mutter GL; Fiane B; Løvslett K
    Hum Pathol; 2005 May; 36(5):555-61. PubMed ID: 15948123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of endometrial intraepithelial neoplasia (EIN) in postmenopausal endometrium.
    Maia H; Maltez A; Athayde C; Coelho G; Coutinho E
    Maturitas; 2003 Oct; 46(2):153-61. PubMed ID: 14559387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria.
    Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Insabato L; Zullo F
    Histopathology; 2019 Apr; 74(5):676-687. PubMed ID: 30347477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dusp6 immunohistochemistry is associated with the response of atypical endometrial hyperplasia and early endometrial cancer to conservative treatment.
    Travaglino A; Raffone A; Gencarelli A; Micheli M; Franco L; Zullo F; Mollo A; Di Spiezio Sardo A; Bifulco G; Insabato L
    Int J Gynaecol Obstet; 2022 Sep; 158(3):742-747. PubMed ID: 34837386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lesions sub-diagnostic of endometrioid intra-epithelial neoplasia/atypical hyperplasia: value of morphology and immunohistochemistry in predicting neoplastic outcome.
    Wyvekens N; Mutter GL; Nucci MR; Kolin DL; Parra-Herran C
    Histopathology; 2024 Oct; 85(4):579-589. PubMed ID: 38785042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
    Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
    Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
    Younes SF; Aiad H; Kandil M; El Kalashy FS
    Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis.
    Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():104-110. PubMed ID: 30342311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supervised clustering of immunohistochemical markers to distinguish atypical and non-atypical endometrial hyperplasia.
    Laas E; Ballester M; Cortez A; Gonin J; Canlorbe G; Daraï E; Graesslin O
    Gynecol Endocrinol; 2015 Apr; 31(4):282-5. PubMed ID: 25495249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
    Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
    Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?
    Naaman Y; Diment J; Perlman S; Oustinov N; Vaisbuch E; Ben-Arie A
    Gynecol Oncol; 2015 Feb; 136(2):254-7. PubMed ID: 25524459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial intraepithelial neoplasia.
    Owings RA; Quick CM
    Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
    Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
    Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5.
    Obstet Gynecol; 2023 Sep; 142(3):735-744. PubMed ID: 37590985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
    Raffone A; Catena U; Travaglino A; Masciullo V; Spadola S; Della Corte L; Piermattei A; Insabato L; Zannoni GF; Scambia G; Zullo F; Bifulco G; Fanfani F; Di Spiezio Sardo A
    Gynecol Oncol; 2021 Jun; 161(3):795-801. PubMed ID: 33812697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The premalignant disease of the endometrium: endometrial intraepithelial neoplasia].
    Francz M
    Magy Onkol; 2008 Mar; 52(1):35-40. PubMed ID: 18403295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.
    Lee H; Choi HJ; Kang CS; Lee HJ; Lee WS; Park CS
    Mod Pathol; 2012 Nov; 25(11):1508-15. PubMed ID: 22766795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical reaction of the glandular epithelium in endometrial hyperplasia compared to endometrial carcinoma.
    Stoenescu VE; Niculescu M; Novac L; Manolea MM; Tomescu PI; Dijmărescu AL; Novac MB; Tudorache Ş; Iliescu DG
    Rom J Morphol Embryol; 2017; 58(3):791-800. PubMed ID: 29250656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.